Home » Meridian Bioscience Receives Canadian License for Illumigene C. Difficile
Meridian Bioscience Receives Canadian License for Illumigene C. Difficile
Meridian Bioscience, Inc., Thursday announced that it has received an approved medical device license from Health Canada for its new molecular amplification assay, illumigene C. difficile.
Morningstar
Morningstar
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May